NCT06274515 2026-03-09
REMERGE
Hoffmann-La Roche
Phase 4 Recruiting
Hoffmann-La Roche
Full-Life Technologies GmbH
Nucleix Ltd.
ADVANCED MARKER DISCOVERY S.L.
Janssen Research & Development, LLC
Paradigm Health
Freenome Holdings Inc.
EBG MedAustron GmbH
JaxBio Ltd